Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial

Investigational New Drugs ◽

10.1007/s10637-021-01206-2 ◽

2022 ◽

Author(s):

Daobin Zhou ◽

Wei Xu ◽

Hongbing Ma ◽

Chunting Zhao ◽

Yu Hu ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Phase Iii ◽

Phase Iii Clinical Trial

Download Full-text

A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator’s choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141

Oral Oncology ◽

10.1016/j.oraloncology.2017.07.023 ◽

2017 ◽

Vol 73 ◽

pp. 138-146 ◽

Author(s):

Naomi Kiyota ◽

Yasuhisa Hasegawa ◽

Shunji Takahashi ◽

Tomoya Yokota ◽

Chia-Jui Yen ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Asian Patients ◽

Recurrent Squamous Cell Carcinoma ◽

Open Label Phase ◽

Global Population

Download Full-text

003 A single-arm, open-label phase III clinical trial of autologous fibroblast transplantation for facial contour deformities; long-term follow up

Journal of Investigative Dermatology ◽

10.1016/j.jid.2016.06.020 ◽

2016 ◽

Vol 136 (9) ◽

pp. S161

Author(s):

S. Shafieyan ◽

A. Bajouri ◽

N. Aghdami

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Facial Contour ◽

Open Label Phase ◽

Long Term Follow Up

Download Full-text

Measurement of viral interferon sensitivity in patients with chronic hepatitis C. Prospective, randomised, open label phase III clinical trial

Journal of Hepatology ◽

10.1016/s0168-8278(02)80486-x ◽

2002 ◽

Vol 36 ◽

pp. 135-136 ◽

Author(s):

Wolfgang Vogel ◽

Harald Brunner ◽

Werner Lin ◽

Rudolf Stauber ◽

Karin Ptacek-Wegerer ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text

The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)

Transplantation Proceedings ◽

10.1016/s0041-1345(01)02383-1 ◽

2001 ◽

Vol 33 (7-8) ◽

pp. 3256-3258 ◽

Author(s):

D.K. Cho ◽

J.H. Kim ◽

S.H. Park ◽

J.C. Kim ◽

C.D. Kim ◽

...

Keyword(s):

Clinical Trial ◽

Living Donor ◽

Phase Iii ◽

Study Phase ◽

Efficacy And Safety ◽

Donor Kidney ◽

Phase Iii Clinical Trial ◽

Donor Kidney Transplantation ◽

Living Donor Kidney

Download Full-text

Validity Of Patient-Reported Outcomes From Columbus, A Randomized Open Label Phase Iii Clinical Trial Of Encorafenib Plus Binimetinib VS Vemurafenib In Advanced Braf-Mutant Melanoma

Value in Health ◽

10.1016/j.jval.2018.04.318 ◽

2018 ◽

Vol 21 ◽

pp. S38

Author(s):

N Rahhali ◽

Y Chalem ◽

J Niemira ◽

CW van Gils ◽

C Blome ◽

...

Keyword(s):

Clinical Trial ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Patient Reported ◽

Open Label Phase ◽

Download Full-text

Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13922 ◽

2019 ◽

Vol 22 (4) ◽

pp. 540-548 ◽

Author(s):

Eiichi Araki ◽

Hirotaka Watada ◽

Yasuko Uchigata ◽

Osamu Tomonaga ◽

Hitomi Fujii ◽

...

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text

PCN141 Quality of Life in Small Cell Lung Cancer: Results of an Open-Label Phase III Clinical Trial

Value in Health ◽

10.1016/j.jval.2011.08.1242 ◽

2011 ◽

Vol 14 (7) ◽

pp. A460

Author(s):

S. Hudgens ◽

J. King ◽

Z.M. Khan

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Clinical Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text

A randomized, open-label, prospective, multicenter phase-III clinical trial of Elores in lower respiratory tract and urinary tract infections

Journal of Pharmacy Research ◽

10.1016/j.jopr.2013.04.011 ◽

2013 ◽

Vol 6 (4) ◽

pp. 409-414 ◽

Author(s):

Manu Chaudhary ◽

Anurag Payasi

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Respiratory Tract ◽

Urinary Tract Infections ◽

Lower Respiratory Tract ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Tract Infections

Download Full-text

Review for "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial"

10.1111/dom.13922/v1/review3 ◽

2019 ◽

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text

Decision letter for "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial"

10.1111/dom.13922/v1/decision1 ◽

2019 ◽

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text